News and Events
Vibiosphen is proud to be part of a grooming ecosystem, we will be please to meet in these event
Vibiosphen is attending and presenting at the Adebiotech event : Alternative technologies and models (NAMs) to Reduce the use of laboratory animals in Industry.
Patricia Martin (CSO of Vibiosphen) will be presenting our model innovation in respiratory disease : the apical out lung organoids.
Vibiosphen will be attending #ECCMID2023 in Copenhagen from 15th to 18th of April. We are excited to discover all the great science being done in the field of antimicrobials.
We will be pleased to talk about your project / science and to discuss how to push it one step forward in the preclinical space.
Our Organ Modelling Congress addresses an important and expanding field which provides new understandings in organ functionality and novel approaches to drug
development. These engineered human organs using Organ-on-a-Chip, Tissue-on-a-Chip & Organoids are a remarkable tool
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
Integrating a One Health approach in the decision-making process is key for anticipating and tackling crises linked to emerging and reemerging pathogens that affect humans, animals or both
Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater ...